Data Foundry

Drug recalls 2023

TUMS Antacid — Class II drug recall D-0074-2024

Completed recall by GlaxoSmithKline Consumer Healthcare Holdings LLC, reported 2023-11-08, distributed nationwide. Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.

Recall numberD-0074-2024
Product typeDrug
ClassificationClass II
StatusCompleted
Voluntary or mandatedVoluntary
Recalling firmGlaxoSmithKline Consumer Healthcare Holdings LLC, Saint Louis, MO, United States
Recall initiated2022-12-02
Classified2023-10-27
Reported by FDA2023-11-08
DistributedNationwide (US)
Reason classesforeign material
NDC00135-0118, 00135-0118-01, 00135-0118-04, 00135-0118-14, 00135-0118-83, 00135-0180, 00135-0180-01, 00135-0180-02, 00135-0180-14, 00135-0181, 00135-0181-01, 00135-0181-02, 00135-0181-03, 00135-0181-05, 00135-0181-06, 00135-0181-07, 00135-0181-14, 00135-0228, 00135-0228-01, 00135-0228-04, 00135-0228-05, 00135-0228-06, 00135-0228-07, 00135-0540, 00135-0540-01 and 1 more
Lot numbersHA7G
Expiration dates2027-08-31

Product

TUMS Antacid, Calcium Carbonate USP 1000 mg, Peppermint flavor, chewable tablets, packaged in 12-count roll, Dist. by: GSK CH, Warren, NJ 07059. NDC: 0135-0228-01, UPC 3-0766-0746-80-5

Reason for recall

Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0074-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.